v1
Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Identifier:nobleid.org/w1/20260515/1DFE8564
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/1DFE8564)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims